Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study (Ophthalmology and Therapy, (2020), 10.1007/s40123-020-00280-8)
Author
Farooq, Asim V.Degli Esposti, Simona
Popat, Rakesh
Thulasi, Praneetha
Lonial, Sagar
Nooka, Ajay K.
Jakubowiak, Andrzej
Sborov, Douglas
Zaugg, Brian E.
Badros, Ashraf Z.
Jeng, Bennie H.
Callander, Natalie S.
Opalinska, Joanna
Baron, January
Piontek, Trisha
Byrne, Julie
Gupta, Ira
Colby, Kathryn
Date
2020-09-12Journal
Ophthalmology and TherapyPublisher
Springer NatureType
Article
Metadata
Show full item recordAbstract
The authors of the above mentioned article would like to highlight the corrections in https://doi.org/10.1007/s40123-020-00289-z, based upon recent changes to the FDA label and guidance on the use of belamaf.Description
Original article at https://doi.org/10.1007/s40123-020-00280-8Identifier to cite or link to this item
http://hdl.handle.net/10713/13764ae974a485f413a2113503eed53cd6c53
10.1007/s40123-020-00289-z